M&G invests in UK-based innovator e-therapeutics

by | Dec 7, 2022

Share this article

M&G Investments has provided a further £13.5 million of funding and an increased shareholding in e-therapeutics, a UK-based innovator in computer technology for the development of life-transforming medicines.

e-therapeutics combines two platform technologies; a computational drug discovery platform and its specialised silenced RNA drugs, which target the liver specifically. The combination of these technologies shortens the time and cost it takes a drug from target discovery to market, which currently takes on average, around 10 years.

The additional funding will be used to scale up e-therapeutics’ operations and facilitate further growth, including enhancing its proprietary drug discovery and development platform capabilities. The investment is being facilitated through the issuance of Subscription Shares, increasing M&G’s holding in the company to 17.5%, signalling its long term commitment to supporting e-therapeutics’ aims and ambitions.

Michael Stiasny. Head of UK Equities at M&G Investments says: “With the potential to re-shape the conventional drug discovery model, we believe e-therapeutics’ unique platform and AI capabilities has the potential to increase the speed in which highly-specific drugs can be developed for patients, while increasing efficiency and reducing the costs associated with in-vitro trials. This investment demonstrates the crucial role patient capital can play in supporting the next generation of medical research.”

 

Ali Mortazavi, Chief Executive Officer of e-therapeutics says: “We are pleased to have continued our long-standing relationship with M&G, and this refinancing is an important step in us extending our cash runway and ability to prosecute our computationally derived drug targets.”

Share this article

Related articles

Venture Capital Trusts (VCT) | Annual Report 2023

Venture Capital Trusts (VCT) | Annual Report 2023

Welcome to the ‘Venture Capital Trusts Report 2023’ the third in our series of focused reports on the tax efficient sector. Our four reports will be brought together as one major report covering the whole sector to be published later in February. IFA/GBI Magazine...

Trending articles

IFA Talk logo

IFA Talk is our flagship podcast, designed to fit perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.

IFA Talk Podcast - listen to the latest episode